🔎 Trials Near Me

Почетна › Рак дојке › Тексас › Sugar Land

Kliničke studije za Рак дојке u gradu Sugar Land, TX

8 studija za Рак дојке traži učesnike na lokacijama u gradu Sugar Land i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07318805

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Тражи се учесникФаза 3
  • UT MD Anderson - Sugar Land, Sugar Land
  • Houston Methodist Sugar Land Hospital, Sugar Land
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Тражи се учесникФаза 3
  • MD Anderson in Sugar Land, Sugar Land
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07062965

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

Тражи се учесникОпсервациона студија
  • MD Anderson in Sugar Land, Sugar Land
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT00477100

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Тражи се учесникФаза 3
  • Research Site, Sugar Land
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT06103864

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Тражи се учесникФаза 3
  • Texas Oncology - Gulf Coast, Sugar Land
Узраст од 18 до 100 · Оба пола · Ажурирано 6. 8. 2026. · NCT05232916

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Тражи се учесникФаза 3
  • MD Anderson in Sugar Land, Sugar Land
  • Houston Methodist Sugar Land Hospital, Sugar Land
Узраст од 50 до 70 · Оба пола · Ажурирано 23. 4. 2026. · NCT04852887

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Тражи се учесникОпсервациона студија
  • Texas Oncology - Sugar Land, Sugar Land
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2025. · NCT03053193

Studije za Рак дојке u drugim gradovima

Ostale studije u gradu Sugar Land

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.